Feedback, Crosstalk and Competition: Ingredients for Emergent Non-Linear Behaviour in the PI3K/mTOR Signalling Network.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
28 Jun 2021
Historique:
received: 14 05 2021
revised: 20 06 2021
accepted: 23 06 2021
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 10 8 2021
Statut: epublish

Résumé

The PI3K/mTOR signalling pathway plays a central role in the governing of cell growth, survival and metabolism. As such, it must integrate and decode information from both external and internal sources to guide efficient decision-making by the cell. To facilitate this, the pathway has evolved an intricate web of complex regulatory mechanisms and elaborate crosstalk with neighbouring signalling pathways, making it a highly non-linear system. Here, we describe the mechanistic biological details that underpin these regulatory mechanisms, covering a multitude of negative and positive feedback loops, feed-forward loops, competing protein interactions, and crosstalk with major signalling pathways. Further, we highlight the non-linear and dynamic network behaviours that arise from these regulations, uncovered through computational and experimental studies. Given the pivotal role of the PI3K/mTOR network in cellular homeostasis and its frequent dysregulation in pathologies including cancer and diabetes, a coherent and systems-level understanding of the complex regulation and consequential dynamic signalling behaviours within this network is imperative for advancing biology and development of new therapeutic approaches.

Identifiants

pubmed: 34203293
pii: ijms22136944
doi: 10.3390/ijms22136944
pmc: PMC8267830
pii:
doi:

Substances chimiques

MTOR protein, human EC 2.7.1.1
Proto-Oncogene Proteins c-akt EC 2.7.11.1
TOR Serine-Threonine Kinases EC 2.7.11.1

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Victorian Cancer Agency
ID : MCRF18026
Organisme : Cancer Council Victoria
ID : Metcalf Venture Grants Scheme
Organisme : National Breast Cancer Foundation
ID : IIRS-20-094

Références

Cell. 1998 Oct 2;95(1):29-39
pubmed: 9778245
Nat Rev Mol Cell Biol. 2001 Oct;2(10):769-76
pubmed: 11584304
Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20517-22
pubmed: 18077353
Trends Biochem Sci. 2011 Jun;36(6):320-8
pubmed: 21531565
J Biol Chem. 1998 Jul 10;273(28):17720-5
pubmed: 9651371
Proc Natl Acad Sci U S A. 2015 Jul 28;112(30):9406-11
pubmed: 26170313
Mol Cell. 2009 Dec 11;36(5):894-9
pubmed: 20005851
J Biol Chem. 2019 Nov 8;294(45):16729-16739
pubmed: 31548312
Cell Cycle. 2015;14(2):189-99
pubmed: 25607644
Nat Cancer. 2021 Mar;2(3):271-283
pubmed: 33870211
J Biol Chem. 2010 Jan 1;285(1):80-94
pubmed: 19864431
PLoS Comput Biol. 2018 Jun 19;14(6):e1006192
pubmed: 29920512
Cell. 2012 Apr 13;149(2):274-93
pubmed: 22500797
Cell. 2006 Oct 6;127(1):125-37
pubmed: 16962653
Nat Cell Biol. 2013 Nov;15(11):1263-5
pubmed: 24189516
Cell Metab. 2016 Jan 12;23(1):27-47
pubmed: 26771115
Cancer Cell. 2012 Oct 16;22(4):438-51
pubmed: 23079655
J Clin Invest. 2018 Mar 1;128(3):1010-1025
pubmed: 29400692
Cell Commun Signal. 2009 Jun 17;7:14
pubmed: 19534786
Cell Cycle. 2004 Oct;3(10):1221-4
pubmed: 15467468
J Biol Chem. 2017 Aug 25;292(34):14240-14249
pubmed: 28630042
Biochim Biophys Acta. 2011 Nov;1813(11):1978-86
pubmed: 21440011
Mol Biosyst. 2015 Oct;11(10):2750-62
pubmed: 26266875
Genes (Basel). 2016 Jun 17;7(6):
pubmed: 27322327
Cancer Discov. 2019 Apr;9(4):482-491
pubmed: 30867161
Mol Cell Biol. 2010 Feb;30(4):908-21
pubmed: 19995915
Science. 2011 Jun 10;332(6035):1322-6
pubmed: 21659605
PLoS Genet. 2009 Feb;5(2):e1000374
pubmed: 19214224
Mol Cell. 2005 Apr 1;18(1):13-24
pubmed: 15808505
J Biol Chem. 2004 Aug 6;279(32):33759-67
pubmed: 15175348
Mol Cancer Ther. 2016 Mar;15(3):347-53
pubmed: 26916116
Nat Rev Drug Discov. 2020 Jul;19(7):480-494
pubmed: 32555376
Mol Cell. 2016 Jun 16;62(6):929-942
pubmed: 27237051
Dev Cell. 2006 Dec;11(6):859-71
pubmed: 17141160
J Biol Chem. 2009 Aug 21;284(34):22525-34
pubmed: 19561084
Mol Cancer. 2019 Feb 19;18(1):26
pubmed: 30782187
Nat Metab. 2020 Jan;2(1):41-49
pubmed: 31993556
Mol Cell. 2008 Apr 25;30(2):214-26
pubmed: 18439900
Int J Oncol. 2009 Oct;35(4):731-40
pubmed: 19724909
Nat Rev Cancer. 2008 Sep;8(9):671-82
pubmed: 18650841
J Biol Chem. 2000 Sep 1;275(35):27354-9
pubmed: 10869359
J Clin Invest. 1997 Mar 1;99(5):830-7
pubmed: 9062339
Mol Cell Biol. 2006 Sep;26(17):6425-34
pubmed: 16914728
Cell. 2010 Jun 25;141(7):1117-34
pubmed: 20602996
Mol Cell Biol. 2009 Dec;29(23):6192-205
pubmed: 19797085
Cancer Discov. 2015 Nov;5(11):1194-209
pubmed: 26293922
Nat Commun. 2017 Apr 21;8:15074
pubmed: 28429737
Cell. 1999 Mar 19;96(6):857-68
pubmed: 10102273
Proc Natl Acad Sci U S A. 2013 Feb 12;110(7):2569-74
pubmed: 23359693
Mol Cell. 2012 Dec 28;48(6):875-87
pubmed: 23142081
Oncogene. 2006 Aug 28;25(38):5220-7
pubmed: 16936740
Nature. 2017 May 18;545(7654):365-369
pubmed: 28489822
Mol Cell Biol. 2011 Dec;31(24):4917-27
pubmed: 21986499
Mol Cell. 2003 Jan;11(1):11-23
pubmed: 12535517
Cell. 1993 May 7;73(3):499-511
pubmed: 8490963
Mol Cell Biol. 1993 Dec;13(12):7418-28
pubmed: 7504175
J Biol Chem. 2011 Apr 1;286(13):10998-1002
pubmed: 21310961
Nat Cell Biol. 2012 Dec;14(12):1322-9
pubmed: 23143395
J Cell Sci. 2007 Aug 1;120(Pt 15):2479-87
pubmed: 17646672
Mol Cell. 2007 Mar 23;25(6):917-31
pubmed: 17386267
Mol Cell Biol. 2000 Feb;20(4):1448-59
pubmed: 10648629
Nature. 2014 Apr 24;508(7497):541-5
pubmed: 24670654
Cell. 2007 Jun 1;129(5):957-68
pubmed: 17540175
Science. 2011 Jun 10;332(6035):1317-22
pubmed: 21659604
Oxid Med Cell Longev. 2018 Oct 30;2018:7838647
pubmed: 30510625
J Biol Chem. 1995 Jul 28;270(30):18083-7
pubmed: 7629118
Sci Rep. 2018 Jan 12;8(1):643
pubmed: 29330362
Cancer Drug Resist. 2019 Dec 19;2(4):1106-1126
pubmed: 35582276
PLoS Comput Biol. 2008 Nov;4(11):e1000235
pubmed: 19043543
Nat Commun. 2016 Nov 21;7:13254
pubmed: 27869123
Cell. 2005 Jul 29;122(2):261-73
pubmed: 16051150
Nature. 2004 Feb 19;427(6976):737-40
pubmed: 14973486
Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):11980-5
pubmed: 14530388
Int J Cancer. 2009 Dec 15;125(12):2863-70
pubmed: 19609947
J Cell Biol. 2004 Jul 19;166(2):213-23
pubmed: 15249583
Biochemistry. 2004 Sep 28;43(38):12133-40
pubmed: 15379552
Am J Physiol Cell Physiol. 2011 May;300(5):C1172-80
pubmed: 21289294
EMBO J. 2007 Oct 31;26(21):4523-34
pubmed: 17932490
J Biol Chem. 1997 Jan 31;272(5):2659-67
pubmed: 9006901
PLoS One. 2010 Mar 09;5(3):e9616
pubmed: 20231902
Cancer Res. 2010 Feb 1;70(3):1195-203
pubmed: 20086174
Cell. 2017 Mar 9;168(6):960-976
pubmed: 28283069
Cell. 1995 May 5;81(3):323-30
pubmed: 7736585
Cell Metab. 2016 Jun 14;23(6):990-1003
pubmed: 27304501
Science. 1999 Nov 26;286(5445):1741-4
pubmed: 10576742
J Biol Chem. 2014 Sep 5;289(36):25227-40
pubmed: 24990947
Mol Cell. 2017 Jul 6;67(1):128-138.e7
pubmed: 28648777
Cell Res. 2016 Jan;26(1):46-65
pubmed: 26584640
Biochim Biophys Acta. 2011 Aug;1813(8):1453-64
pubmed: 21621563
EMBO J. 2002 Jan 15;21(1-2):64-71
pubmed: 11782426
J Cell Biol. 1998 Dec 14;143(6):1661-72
pubmed: 9852158
Mol Cancer Res. 2016 Feb;14(2):127-40
pubmed: 26432795
Mol Cell. 2015 Oct 15;60(2):195-207
pubmed: 26474064
J Biol Chem. 2015 Mar 13;290(11):6986-93
pubmed: 25632961
J Biol Chem. 2015 Aug 7;290(32):19387-401
pubmed: 25998128
J Physiol. 2017 Jul 15;595(14):4845-4855
pubmed: 28464351
Nat Cell Biol. 2014 Jul;16(7):673-84
pubmed: 24929361
Nature. 1994 Aug 18;370(6490):527-32
pubmed: 8052307
J Biol Chem. 2011 Feb 25;286(8):6510-20
pubmed: 21177869
Oncotarget. 2016 Apr 19;7(16):21064-75
pubmed: 27027448
Elife. 2017 Jun 07;6:
pubmed: 28589878
Cancer Biol Med. 2014 Dec;11(4):255-63
pubmed: 25610711
J Biol Chem. 2008 Mar 7;283(10):6300-11
pubmed: 18162466
Semin Cell Dev Biol. 2004 Apr;15(2):161-70
pubmed: 15209375
Mol Cell. 2003 Jun;11(6):1457-66
pubmed: 12820960
Cell. 2003 Nov 26;115(5):577-90
pubmed: 14651849
Genes Dev. 2005 Oct 15;19(20):2435-46
pubmed: 16230533
Oncogene. 2012 Mar 8;31(10):1264-74
pubmed: 21804599
J R Soc Interface. 2012 Aug 7;9(73):1998-2010
pubmed: 22417908
J Cell Sci. 2009 Oct 15;122(Pt 20):3589-94
pubmed: 19812304
Cell. 2009 May 29;137(5):873-86
pubmed: 19446321
J Biol Chem. 2000 Dec 29;275(52):41201-9
pubmed: 10995762
Annu Rev Microbiol. 2019 Sep 8;73:199-223
pubmed: 31112439
Cell Rep. 2015 Aug 11;12(6):937-43
pubmed: 26235620
EMBO J. 1996 Dec 2;15(23):6541-51
pubmed: 8978681
Mol Cell. 2021 Feb 18;81(4):708-723.e5
pubmed: 33606974
Biochem Soc Trans. 2014 Aug;42(4):816-21
pubmed: 25109963
J Exp Clin Cancer Res. 2017 Sep 29;36(1):136
pubmed: 28962630
Biochim Biophys Acta. 2011 Nov;1813(11):1938-45
pubmed: 21708191
PLoS Comput Biol. 2021 Sep 16;17(9):e1008513
pubmed: 34529665
Science. 2008 Oct 17;322(5900):390-5
pubmed: 18927383
Cell. 2018 Aug 9;174(4):897-907.e14
pubmed: 30078705
Dev Cell. 2013 Mar 11;24(5):459-71
pubmed: 23484853
Cold Spring Harb Perspect Biol. 2009 Dec;1(6):a001651
pubmed: 20457564
Int J Mol Sci. 2017 Feb 11;18(2):
pubmed: 28208660
Science. 2012 Mar 30;335(6076):1638-43
pubmed: 22461615
Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):1822-7
pubmed: 14766974
Int J Mol Sci. 2019 Feb 11;20(3):
pubmed: 30754640
Science. 2005 Feb 18;307(5712):1098-101
pubmed: 15718470
PLoS One. 2012;7(10):e47741
pubmed: 23077666
Cell Cycle. 2015;14(20):3331-9
pubmed: 26323019
Elife. 2021 Jul 13;10:
pubmed: 34253290
Cell Commun Signal. 2009 Sep 08;7:22
pubmed: 19737390
Int J Oncol. 2018 Dec;53(6):2319-2331
pubmed: 30334567
Curr Biol. 1994 Sep 1;4(9):798-806
pubmed: 7820549
J Biol Chem. 2011 Jan 7;286(1):567-77
pubmed: 21071439
Oncogene. 2010 Feb 18;29(7):1003-16
pubmed: 19935711
Mol Cell. 2011 Oct 21;44(2):304-16
pubmed: 22017876
Nat Rev Cancer. 2013 Apr;13(4):246-57
pubmed: 23467301
Curr Opin Cell Biol. 2003 Apr;15(2):221-31
pubmed: 12648679
Physiol Rev. 2018 Jul 1;98(3):1765-1803
pubmed: 29897294
Nature. 1995 Dec 21-28;378(6559):785-9
pubmed: 8524413
Mol Cell Biol. 2008 Oct;28(19):5886-98
pubmed: 18644865
Int J Mol Sci. 2020 Dec 02;21(23):
pubmed: 33276499
Nat Cell Biol. 2013 Nov;15(11):1340-50
pubmed: 24161930
Genes (Basel). 2016 Aug 05;7(8):
pubmed: 27527217
Semin Cell Dev Biol. 2016 Feb;50:85-94
pubmed: 26481970

Auteurs

Milad Ghomlaghi (M)

Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Clayton, VIC 3800, Australia.
Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.

Anthony Hart (A)

Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Clayton, VIC 3800, Australia.
Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.

Nhan Hoang (N)

Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Clayton, VIC 3800, Australia.

Sungyoung Shin (S)

Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Clayton, VIC 3800, Australia.
Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.

Lan K Nguyen (LK)

Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Clayton, VIC 3800, Australia.
Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH